|
| |
| | Guideline 68 Section 5: Management of functional dyspepsia |
 | | However, when prescription of medication is being contemplated, clinicians should appreciate that in functional dyspepsia, as in all other functional GI disorders, there is a substantial placebo response to therapy that constrains the interpretation of apparent treatment effectiveness in individual patients. | | | Functional dyspepsia is very common and is not itself serious, though the discomfort, pain, distension and fullness which are perfectly genuine, are often unpleasant and bothersome. | | | No drug therapies have been found to have a high success rate in the treatment of functional dyspepsia though it should also be acknowledged that there is no scientific basis for supposing that all patients with functional dyspepsia should respond to the same pharmacological approach. |
|
http://www.sign.ac.uk/guidelines/fulltext/68/section5.html
(2061 words)
|
|
| |
| | Dyspepsia in Children |
| | In ulcer-like dyspepsia, the predominant symptom is pain centered in the upper abdomen; the pain is often relieved by food or antacid therapy and may wake the child from sleep. | | | For functional dyspepsia, the aim is to provide symptomatic relief. | | | In addition, these patients also had high-pressure duodenal contractions that were associated with abdominal pain during the study period. |
|
http://www.aboutkidsgi.org/Dyspepsia.html
(1231 words)
|
|
| |
| | Dyspepsia — Complete medical information on this disease of the gastrointestinal track on MedicineNet.com |
| | For example, functional diseases of the stomach and intestines may be shown ultimately to be associated with reduced or increased levels of normal chemicals within the gastrointestinal organs, the spinal cord, or the brain. | | | The amount of research that has been done with functional disorders is greatest in the esophagus and stomach (e.g., non-cardiac chest pain, dyspepsia), perhaps because these organs are easiest to reach and study. | | | A third distinct functional disorder is non-cardiac chest pain. |
|
http://www.medicinenet.com/dyspepsia/article.htm
(1124 words)
|
|
| |
| | Dyspepsia — clinical trials and research studies for functional dyspepsia |
| | If you would like to be a part of our clinical trials and research studies for functional dyspepsia please contact us. | | | Dyspepsia — clinical trials and research studies for functional dyspepsia | | | Our dyspepsia clinical trials are fully supervised and observed by renowned physicians in the gastrointestinal field. |
|
http://www.liclinical.com/dyspepsia.htm
(414 words)
|
|
| |
| | Dyspepsia |
| | The standard medical approach to dyspepsia begins by looking for an identifiable medical condition such as gallstones, ulcers, or esophageal reflux. | | | After 4 weeks, the herbal combination reduced dyspepsia pain by 69.7%, whereas the conventional treatment reduced pain by 70.2%. | | | By the third week of treatment, individuals taking red pepper were experiencing significant improvements in pain, bloating, and nausea as compared to placebo, and these relative improvements lasted through the end of the study. |
|
http://healthlibrary.epnet.com/GetContent.aspx?token=e0498803-7f62-4563-8d47-5fe33da65dd4&chunkiid=21605
(1869 words)
|
|
| |
| | Literature Summary |
| | UK MRC trial of Helicobacter pylori eradication therapy for non-ulcer dyspepsia. | | | Many dyspepsia patients will want to be investigated for Helicobaacter pylori and treated if positive. | | | pylori does not influence the long-term symptomatic response in patients with functional dyspepsia. |
|
http://meds.queensu.ca/gimec/nf99vanz.htm
(1688 words)
|
|
| |
| | Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with ... |
| | Non-ulcer dyspepsia and short-term de-nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori. | | | A few studies have observed that a treatment response was limited to those patients with ulcer-like dyspepsia, but no link between dyspepsia subgroups and H pylori eradication was evident in the present study. | | | Ulcer-like dyspepsia was defined as at least moderate stomach pain and hunger pain in the week before follow up. |
|
http://bmj.bmjjournals.com/cgi/content/full/318/7187/833/DC1
(4123 words)
|
|
| |
| | BioMed Central Abstract Delayed Gastric Emptying in Functional Dyspepsia |
| | Future clinical trials should be performed so that the formal structure required by good clinical practice can be adapted to detect significant effects in subgroups of patients with functional dyspepsia. | | | The identification of the mechanisms leading to symptom generation should facilitate the development of newer and more effective therapeutic strategies in functional dyspepsia. | | | Abnormalities in gastrointestinal motility and sensitivity alone or combined seem to play a role in a substantial subgroup of patients. |
|
http://www.biomedcentral.com/1092-8472/7/259/abstract
(323 words)
|
|
| |
| | Functional (Non-Ulcer) Dyspepsia - Patient UK |
| | There has been little research done to prove how effective these medicines are for functional dyspepsia, but one may be worth a try if other treatments do not help. | | | The muscles in the stomach wall may not work as well as they should. | | | Functional (Non-Ulcer) Dyspepsia - Patient UK Functional (Non-Ulcer) Dyspepsia |
|
http://www.patient.co.uk/showdoc.asp?doc=23069186
(1395 words)
|
|
| |
| | DDW: New Data Shows Tegaserod is Safe and Well Tolerated In Treating Functional Dyspepsia |
| | The baseline characteristics of the patients were similar across all treatment groups: 71 percent were female with a mean age of 45, and 93 percent were less than 65 years old. | | | Novartis continues to work with the European Agency for the Evaluation of Medicinal Products (EMEA) to help bring the benefits of this important new therapy to patients in need. | | | Functional dyspepsia is a frequently occurring disorder, characterized by early satiety, abdominal distention, fullness, nausea and burning pain localized to the upper abdomen or chest that has no specific cause or diagnostic evaluation. |
|
http://www.docguide.com/dg.nsf/PrintPrint/0ED3FF403BB65DA285256BC0005323BA
(727 words)
|
|
| |
| | functional dyspepsia: can chiropractic help? |
| | Bryner, in one prospective study of human subjects seeking chiropractic care over a six-month period, looked at the prevalence of indigestion and mid-back pain in these patients with dyspepsia. | | | Since the exact cause of FD remains elusive, these latter theories may be the basis for the chiropractic model. | | | The patients in the largest subgroup (50 to 60 percent) presenting with dyspepsia symptoms have no identffiable disease process and are thus said to have functional dyspepsia (FD) or non-ulcer dyspepsia (NUD). |
|
http://www.chiroclinic.com.au/conditions/t4_1.shtml
(659 words)
|
|
| |
| | UpToDate Functional dyspepsia |
| | — The most common type of dyspepsia encountered in primary care and gastroenterology practice is functional (idiopathic) dyspepsia, also referred to as nonulcer dyspepsia [1-4]. | | | An international committee of clinical investigators developed the following revised definition (Rome II criteria) of functional dyspepsia for research purposes, which can also be applied to clinical practice [1]: | | | — The pathophysiology of functional dyspepsia is unclear. |
|
http://patients.uptodate.com/topic.asp?file=acidpep/5193
(394 words)
|
|
| |
| | Hypnosis training for functional gastrointestinal disorders, irritable bowel syndrome, functional dyspepsia, training ... |
| | Hypnosis training for functional gastrointestinal disorders, irritable bowel syndrome, functional dyspepsia, training course for health care professionals taught by Dr. Olafur Palsson, Dr. Peter Whorwell, Dr. Marc Oster, Dr. Sheryll Daniel, Dr. Douglas Drossman. | | | Suited for a range of health professions: Physicians, nurses, nurse practitioners, psychologists, clinical social workers, and others | | | Learn clinical approaches from nationally prominent teachers in clinical hypnosis (Drs. |
|
http://www.ibshypnosis.com/course.html
(548 words)
|
|
| |
| | Links - GI Disorders |
| | Their web site offers up-to-date information on Functional GI and Motility Disorders for both the professional and the patient, and provides information on the Center and its research, training, patient education and clinical treatment. | | | Other disorders can have symptoms that may be similar to or overlap with gastrointestinal functional or motility disorders. | | | The Center seeks better understanding of such common gastrointestinal disorders as irritable bowel syndrome, functional dyspepsia, and common urological disorders such as irritable bladder syndrome (interstitial cystitis). |
|
http://www.iffgd.org/GIDisorders/Other.html
(1793 words)
|
|
| |
| | Functional dyspepsia |
| | It is usually non-serious in that it is not life threatening, but the pain and discomfort can make your life a misery. | | | I have recently heard about functional dyspepsia and think this may the condition I'm suffering from. | | | Functional dyspepsia is the name for indigestion that is not due to a peptic ulcer. |
|
http://www.ivillage.co.uk/health/ghealth/discon/qas/0,,181033_589739,00.html
(359 words)
|
|
| |
| | Functional Dyspepsia |
| | Dr. Kevin Pho who is board certified in Internal Medicine and by doctors from Henry Ford Health System. | | | Functional dyspepsia is basically a diagnoses of exclusion. | | | Also the pain I have in my stomach is sharp and stabbing pain which every where I have looked is not a symptom of Dyspepsia. |
|
http://www.medhelp.org/perl6/gastro/messages/37173.html
(616 words)
|
|
| |
| | BW Online February 13, 2004 Stocks to Love on Valentine's Day |
| | Moroney is encouraged by news that its ITAX has been cleared for the last stage of clinical trials. | | | Axcan says that drug, which treats functional dyspepsia -- an upper gastrointestinal disorder that affects one in four Americans -- could double its business by generating as much as $300 million in annual revenue, Moroney says. | | | Axcan did about $180 million in sales in 2003. |
|
http://www.businessweek.com/bwdaily/dnflash/feb2004/nf20040213_4980_db014.htm
(1723 words)
|
|
| |
| | THE MERCK MANUAL, Sec. 3, Ch. 21, Functional Upper Gastrointestinal Complaints |
| | Functional dyspepsia is generally a benign condition, which, by definition, has no pathologic correlation. | | | Functional dyspepsia usually calls first for reassurance and symptomatic treatment with observation over time. | | | Changes in the clinical state may require more extensive evaluation if new problems arise or if symptoms persist and become more disabling; however, for most patients with functional dyspepsia, continued observation, support, and reassurance, with minimal diagnostic studies, suffice. |
|
http://www.merck.com/mrkshared/mmanual/section3/chapter21/21c.jsp
(509 words)
|
|
| |
| | Functional Dyspepsia |
| | Functional dyspepsia (FD) is defined as chronic upper, centered abdominal discomfort or pain excluding the predominant symptom, heartburn. | | | By strict definition, patients with FD have undergone upper intestinal endoscopy that has revealed no lesions that can explain their symptoms. | | | This discussion of functional dyspepsia is continued in the book, |
|
http://www.nutramed.com/digestion/dyspepsia.htm
(585 words)
|
|
| |
| | Functional bowel disorder - Wikipedia, the free encyclopedia |
| | In medicine, the term functional bowel disorder refers to a group of disorders which are characterised by chronic abdominal complaints without a structural or biochemical cause that could explain symptoms. | | | This page was last modified 12:05, 24 February 2005. |
|
http://en.wikipedia.org/wiki/Functional_bowel_disorder
(64 words)
|
|
| |
| | Axcan Pharma Reports Positive Pre-Ind Meeting for ITAX - Functional Dyspepsia Phase III Studies to be Initiated Upon ... |
| | Functional dyspepsia is a diagnosis of exclusion (diagnosis made by excluding those diseases to which only some of the patient's symptoms might belong, leaving one disease as the most likely diagnosis). | | | Each of these studies will assess the efficacy of ITAX 100 mg tablets in the treatment of functional dyspepsia. | | | This meeting was held in preparation for the filing of an Investigational New Drug ("IND") for ITAX in the treatment of functional dyspepsia (also known as non-ulcer dyspepsia). |
|
http://www.forrelease.com/D20040122/mo086.P1.01222004111958.29901.html
(457 words)
|
|
| |
| | Dyspepsia |
| | Contact information may be found on the page | | | This is one page of 15 in this chapter, 266 in this book, and 4645 in the Family Practice Notebook. | | | These pages are best viewed with Microsoft Internet Explorer 5.0 or greater for full functionality. |
|
http://www.fpnotebook.com/GI264.htm
(155 words)
|
|
|
